{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:05:19Z","timestamp":1770984319270,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.drugalcdep.2011.07.019","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T07:57:11Z","timestamp":1314086231000},"page":"190-195","source":"Crossref","is-referenced-by-count":95,"title":["Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians"],"prefix":"10.1016","volume":"120","author":[{"given":"Chris-Ellyn","family":"Johanson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia L.","family":"Arfken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"di Menza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Roberts","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0005","unstructured":"AAPCC (American Association of Poison Control Center). http:\/\/www.aapcc.org."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine\u2013naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0015","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0376-8716(03)00102-9","article-title":"Postmarketing surveillance for drug abuse","volume":"70","author":"Arfken","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(02)00311-3","article-title":"Postmarketing surveillance of abuse liability of sibutramine","volume":"69","author":"Arfken","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","article-title":"Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians","volume":"39","author":"Arfken","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0030","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(97)00126-1","article-title":"Response rates to mail surveys published in medical journals","volume":"50","author":"Asch","year":"1997","journal-title":"J. Clin. Epidemiol."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2011.07.019_bib0035","first-page":"S17","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2001","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0040","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200510273531724","article-title":"Potential for abuse of buprenorphine in office-based treatment of opioid dependence","volume":"353","author":"Cicero","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0045","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","article-title":"Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002\u20132004","volume":"6","author":"Cicero","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0050","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1124\/jpet.105.090423","article-title":"Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals","volume":"315","author":"Comer","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0065","series-title":"Drug Abuse Warning Network, 2004\u20132009: Detailed Tables: National Estimates, Drug-related Emergency Department Visits, All Drug Misuse and Abuse Visits by Drug","author":"DAWN","year":"2009"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0070","unstructured":"DAWN, 2010. The DAWN report: trends in emergency department visits involving nonmedical use of narcotic pain relievers. <http:\/\/oas.samhsa.gov\/2k10\/DAWN016\/OpioidED.cfm> (18.06.10)."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0075","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMcp013579","article-title":"Clinical practice. Office-based treatment of opioid-dependent patients","volume":"347","author":"Fiellin","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenophine\u2013naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addicition with a sublingual-table of buprenorphine and naloxone","volume":"349","author":"Fudula","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0090","first-page":"777","article-title":"Temgesic abuse","volume":"96","author":"Harper","year":"1983","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0100","series-title":"Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators","author":"JBS International, Inc.","year":"2006"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0115","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v10n03_02","article-title":"The use of buprenorphine and temazepam by drug injectors","volume":"10","author":"Lavelle","year":"1991","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0740-5472(02)00257-X","article-title":"Buprenorphine: blending practice and research","volume":"23","author":"Ling","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","article-title":"Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty","volume":"99","author":"Mark","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0140","unstructured":"McNicholas, L., 2004. SAMHSA Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol, 40. SMA 04-3939. Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0376-8716(85)90062-6","article-title":"Behavioral pharmacology of buprenorphine","volume":"14","author":"Mello","year":"1985","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(88)90053-1","article-title":"Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys","volume":"21","author":"Mello","year":"1988","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Mitchell","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0165","unstructured":"NFLIS (National Forensic Laboratory Information System). Office of Diversion Control, Drug Enforcement Agency, US Department of Justice, Washington, DC. <http:\/\/www.deadiversion.usdoj.gov\/nflis\/index.html>."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0170","first-page":"1083","article-title":"Buprenorphine abuse among opiate addicts","volume":"83","author":"O\u2019Connor","year":"1988","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0175","first-page":"618","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0180","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.amepre.2006.08.017","article-title":"Opioid analgesics and rates of fatal drug poisoning in the United States","volume":"31","author":"Paulozzi","year":"2006","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(93)90036-P","article-title":"The misuse of buprenorphine and a buprenorphine\u2013naloxone combination in Wellington, New Zealand","volume":"33","author":"Robinson","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v26n03_12","article-title":"Abuse of buprenorphine in the United States: 2003\u20132005","volume":"26","author":"Smith","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0447.1992.tb03224.x","article-title":"Cases of buprenorphine abuse in India","volume":"86","author":"Singh","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0200","unstructured":"TEDS, 2007. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Treatment Episode Data Set\u2014Admissions (TEDS-A), 2007 [Computer file]. ICPSR21540-v4. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI (22.04.10)."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0205","unstructured":"TEDS, 2010. The TEDS report: characteristics of substance abuse treatment admissions reporting primary abuse of prescription pain relievers: 1998 and 2008. <http:\/\/oas.samhsa.gov\/2k10\/230\/230PainRelvr2k10.htm> (23.09.10)."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0210","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans: partial agonist and blockage effect","volume":"274","author":"Walsh","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0220","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.07.019_bib0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(00)00166-6","article-title":"The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys","volume":"62","author":"Winger","year":"2001","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611003383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611003383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T03:25:11Z","timestamp":1741490711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871611003383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0376871611003383"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.07.019","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}